Published in Naunyn Schmiedebergs Arch Pharmacol on March 01, 1984
Cl- secretion induced by bile salts. A study of the mechanism of action based on a cultured colonic epithelial cell line. J Clin Invest (1989) 1.14
Absorptive and motor components of the antidiarrhoeal action of loperamide: an in vivo study in pigs. Gut (1991) 0.96
Secretagogue-induced changes in membrane calcium permeability in chicken and chinchilla ileal mucosa. Selective inhibition by loperamide. J Clin Invest (1986) 0.82
Detection of Ki-ras mutations by PCR and differential hybridization and of p53 mutations by SSCP analysis in endoscopically obtained lavage solution from patients with long-standing ulcerative colitis. Am J Gastroenterol (1997) 1.41
[Megaloblastic anemia due to inadequate nutrition]. Dtsch Med Wochenschr (1997) 1.39
[Cyanosis and hourglass nails in chronic liver disease]. Internist (Berl) (1994) 1.39
Asymmetry of osmotic flow in frog intestine: functional and structural correlation. Am J Physiol (1970) 1.34
European Cooperative Crohn's Disease Study (ECCDS): clinical features and natural history. Digestion (1985) 1.11
Supplementation with n-3 fatty acids from fish oil in chronic inflammatory bowel disease--a randomized, placebo-controlled, double-blind cross-over trial. J Intern Med Suppl (1989) 1.07
Water movement across the cecal wall of the germfree rat. Proc Soc Exp Biol Med (1970) 1.03
Anti-inflammatory properties of unfractioned heparin in patients with highly active ulcerative colitis: a pilot study. Am J Gastroenterol (1997) 1.02
Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease. Am J Gastroenterol (1999) 0.96
Goblet cell autoantibodies in patients with inflammatory bowel disease and their first-degree relatives. Gastroenterology (1997) 0.95
Loperamide reduces the intestinal secretion but not the mucosal cAMP accumulation induced by choleratoxin. Naunyn Schmiedebergs Arch Pharmacol (1981) 0.94
Veno-occlusive disease of the liver in patients receiving immunosuppressive therapy. Virchows Arch A Pathol Anat Histol (1982) 0.91
Local epinephrine injection improves the therapeutic effect of Nd-YAG laser treatment of arterial peptic ulcer bleeding. Endoscopy (1988) 0.90
Discrepancy between effects of cholera toxin on net fluid movement and cAMP levels in rat jejunum, ileum, and colon. Dig Dis Sci (1988) 0.89
Ceftriaxone-associated nephrolithiasis. Ann Pharmacother (2000) 0.88
Mycophenolate mofetil: lack of efficacy in chronic active inflammatory bowel disease. Aliment Pharmacol Ther (2000) 0.88
Lack of association between an interleukin-1 receptor antagonist gene polymorphism and ulcerative colitis. Gut (1997) 0.88
[Clofibrate in diabetes insipidus]. Klin Wochenschr (1971) 0.87
[Kinetic study of D-glucose reabsorption in the proximal convoluted tubule of rat kidney]. Pflugers Arch (1969) 0.86
Low dose oral pH modified release budesonide for maintenance of steroid induced remission in Crohn's disease. The Budesonide Study Group. Gut (1998) 0.86
Lipid treatment of inflammatory bowel disease. Curr Opin Clin Nutr Metab Care (1999) 0.85
[Clostridium difficile and antibiotic-associated colitis in risk patients: 2-month epidemiologic study in an intensive care unit]. Klin Wochenschr (1983) 0.84
[Differentiation of the active and passive components of D-glucose transport in the proximal tubule of rat kidney]. Pflugers Arch (1969) 0.84
Hepatobiliary fibropolycystic diseases. Two cases of Caroli's disease. Scand J Gastroenterol Suppl (1987) 0.83
Double pylorus: a hypothesis concerning its pathogenesis. Gastroenterology (1974) 0.83
Antineutrophil and pancreatic autoantibodies in first-degree relatives of patients with inflammatory bowel disease. Scand J Gastroenterol (1998) 0.82
Nucleic acid and protein content of rat cecum mucosa in dietary adaptation-growth by cellular hyperplasia. Pflugers Arch (1977) 0.79
Search for mumps virus genome in intestinal biopsy specimens of patients with IBD. Gastroenterology (1999) 0.79
Factors influencing long-term changes in mental health after interferon-alpha treatment of chronic hepatitis C. Aliment Pharmacol Ther (2009) 0.79
K-ras mutations in sera of patients with colorectal neoplasias and long-standing inflammatory bowel disease. Scand J Gastroenterol (2002) 0.79
Mechanism of action of diphenolic laxatives: the role of adenylate cyclase and mucosal permeability. Digestion (1984) 0.79
p-ANCA target antigens in ulcerative colitis. Z Gastroenterol (1998) 0.78
Passive sugar flux across frog jejunum in vitro. Pflugers Arch (1971) 0.78
Bacterial overgrowth in ileal reservoirs (Koch pouch): extended functional studies. Hepatogastroenterology (1980) 0.78
Sodium chloride transport of normal and dietary enlarged rat cecum in vitro. Digestion (1998) 0.78
Micropuncture experiments with saluretic sulfonamides. Ann N Y Acad Sci (1966) 0.78
Stimulation of sodium transport and Na+-K+-ATPase activity in the hypertrophying rat cecum. Pflugers Arch (1974) 0.78
Antinuclear autoantibodies in patients with inflammatory bowel disease. High prevalence in first-degree relatives. Dig Dis Sci (1997) 0.78
Adaptation of electrolyte transport in rat large intestine after proximal resection. I. Cecum and colon after 60% jejunoilectomy. Pflugers Arch (1986) 0.78
Independence of the activation of mucus and potassium secretion on the inhibition of sodium and water absorption by deoxycholate in rat colon. Naunyn Schmiedebergs Arch Pharmacol (1982) 0.78
Delta 32 mutation of the chemokine-receptor 5 gene in inflammatory bowel disease. Clin Immunol (2001) 0.77
Adding low-dose antidepressants to interferon alpha treatment for chronic hepatitis C improved psychiatric tolerability in a patient with schizoaffective psychosis. Neuropsychobiology (2000) 0.77
Adaptation of electrolyte transport in rat large intestine after proximal resection. II. Colon after 50% jejunoilectomy combined with cecectomy. Pflugers Arch (1986) 0.77
The influence of bisacodyl and deacetylbisacodyl on mucus secretion, mucus synthesis and electrolyte movements in the rat colon in vivo. Eur J Pharmacol (1985) 0.77
[Interferon alpha-associated agranulocytosis during clozapine treatment. Case report and status of current knowledge]. Nervenarzt (2001) 0.77
[Intramural pseudodiverticulosis of the esophagus--a primarily radiologic diagnosis]. Rofo (1979) 0.77
Is the secretagogue effect of deoxycholic acid mediated by the adenylate cyclase-cAMP system. Digestion (1983) 0.77
[Therapy of Crohn diseases--results of a Consensus Conference of the German Society of Digestive and Metabolic Diseases]. Z Gastroenterol (1997) 0.76
Endothelial cell autoantibodies are a marker of disease susceptibility in inflammatory bowel disease but apparently not linked to persistent measles virus infection. Clin Immunol (2000) 0.76
Effects of a small bolus dose of ANF in healthy volunteers and in patients with volume retaining disorders. Klin Wochenschr (1990) 0.76
Alpha1-antitrypsin alleles and phenotypes in patients with inflammatory bowel disease. Scand J Gastroenterol (1998) 0.76
Low blood selenium concentration in Crohn disease. Ann Intern Med (1987) 0.76
Inflammatory bowel disease: no association between allele combinations of the interleukin (IL) I beta and IL-I receptor antagonist gene polymorphisms. Eur J Clin Invest (1998) 0.76
[Fatal drug-induced Lyell syndrome in combined benoxaprofen-aurothioglucose therapy]. MMW Munch Med Wochenschr (1982) 0.75
Inhibition by loperamide of mucus secretion in the rat colon in vivo. Eur J Pharmacol (1989) 0.75
Factor V Leiden mutation in patients with inflammatory bowel disease. Gastroenterology (1999) 0.75
CMV encephalitis during ganciclovir therapy of CMV retinitis. Infection (1991) 0.75
Severe ventricular arrhythmia during pentamidine treatment of AIDS-associated Pneumocystis carinii pneumonia. Infection (1988) 0.75
Decreased cyclic GMP levels in rat cecum mucosa during adaptive stimulation of Na-K-ATPase. Experientia (1979) 0.75
[Antidiuretic effect of carbamazepin in diabetes insipidus]. Klin Wochenschr (1972) 0.75
[Percutaneous transhepatic dilatation of Vater's papilla in choledocholithiasis]. Internist (Berl) (1982) 0.75
[Chlorpropamide for diabetes insipidus]. Dtsch Med Wochenschr (1971) 0.75
[Superfluous diagnosis in gastrointestinal diseases]. Internist (Berl) (1986) 0.75
Influence of vasoactive intestinal peptide, secretin, and Ala4, Val5-secretin on the net movements of electrolytes, fluid, and mucus in the rat colon in vivo. Scand J Gastroenterol Suppl (1987) 0.75
[Transhepatic pancreas puncture as a complication in aimed liver biopsy]. Acta Hepatosplenol (1968) 0.75
Differentiation of secretagogue drugs by chlorpromazine in rat intestine in vivo. Naunyn Schmiedebergs Arch Pharmacol (1983) 0.75
[Maldigestion/malabsorption in exocrine pancreatic insufficiency]. Internist (Berl) (1979) 0.75
Cecal enlargement combined with sodium transport stimulation in rats fed polyethylene glycol. Proc Soc Exp Biol Med (1973) 0.75
[Comparison of the effects of SIN-1, sodium nitroprusside and nitrate derivatives on the inhibition of blood platelet aggregation and activation of soluble platelet guanylate-cyclase]. Pathol Biol (Paris) (1987) 0.75
[Broad beans as a cause of acute hemolytic anemia]. Dtsch Med Wochenschr (1993) 0.75
[Alpha 1-antitrypsin deficiency, liver cirrhosis and pulmonary emphysema (author's transl)]. Leber Magen Darm (1979) 0.75
[Rhino-cranial mucormycosis in acute leukemia]. Dtsch Med Wochenschr (1985) 0.75
[Behavior of cellular cyclic nucleotides after hydrokinetic or ecbolic stimulation of the canine pancreas]. Hoppe Seylers Z Physiol Chem (1981) 0.75
[Chlorpropamide in diabetes insipidus]. Minerva Med (1973) 0.75
A rare but fatal cause of ulcerative colitis. Endoscopy (2002) 0.75
[Intestinal adaptation of electrolyte and water resorption]. Fortschr Med (1975) 0.75
[cAMP concentration, cAMP metabolism and fluid secretion in the jejunum, ileum and colon of the rat caused by cholera toxin]. Z Gastroenterol (1986) 0.75
Renal effects and side effects of diuretics. Int Z Klin Pharmakol Ther Toxikol (1970) 0.75
Evidence against cyclic GMP acting as a direct modulator of active sodium absorption in rat cecum. Experientia (1981) 0.75
Treatment of HBsAg-,HBeAg-positive chronic active hepatitis with adenine arabinoside. A case report with clinical remission and seroconversion to anti-HBs. Hepatogastroenterology (1985) 0.75
Gastric outlet obstruction and pulmonary infiltrate in a patient with Crohn's disease: successful treatment by Billroth-II-resection. Z Gastroenterol (2000) 0.75
Hormones and the stimulated sodium transport in cecum hypertrophy. Pflugers Arch (1975) 0.75
[Stimulation and suppression of sodium transport in the rat cecum]. Pflugers Arch (1972) 0.75
Lack of association between HLA-DRB1 alleles of the major histocompatibility complex and p-ANCA status or clinical characteristics in patients with ulcerative colitis. Z Gastroenterol (1999) 0.75
[Multiple muscle abscesses in a Tibetan woman]. Internist (Berl) (2000) 0.75
[Indirect detection of genetic mutations in colon cancers]. Z Gastroenterol (1999) 0.75
Placebo-controlled trials of omega 3 fatty acids in chronic inflammatory bowel disease. World Rev Nutr Diet (1994) 0.75
[A 28-year-old patient with chronic diarrhea, liver disease, pericarditis and polyarthritis. A case report with special reference to the differential diagnosis of arthritis]. Internist (Berl) (1990) 0.75
[Sucrase-isomaltase deficiency as a cause of chronic diarrhoea in adults (author's transl)]. Dtsch Med Wochenschr (1974) 0.75
Induction of Na-K-ATPase in plasma membranes to rat cecum mucosa by diet: time course and kinetics. Pflugers Arch (1977) 0.75
[Asymmetry of osmotic water flow in the small intestine of the ox frog in vitro: functional and morphologic results]. Pflugers Arch (1969) 0.75
[26-year-old female patient with elevated liver enzymes]. Z Gastroenterol (2002) 0.75
Closure of an enterocutaneous fistula by high dose intravenous immune globuline therapy in a patient with X-linked agammaglobulinemia. Am J Gastroenterol (2001) 0.75
[On the karyogram of the human liver in normal and pathological conditions]. Virchows Arch Pathol Anat Physiol Klin Med (1966) 0.75